id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2002-P-0291-0005,FDA,FDA-2002-P-0291,FDA/OC to Johnson & Johnson,Other,PAV-Petition Approval,2003-04-17T04:00:00Z,2003,4,,,2008-04-12T01:28:02Z,,0,0,090000648049eef0
FDA-2002-P-0291-0004,FDA,FDA-2002-P-0291,FDA/DDM to Ortho-McNeil,Other,ACK-Acknowledgement Letter,2002-07-02T04:00:00Z,2002,7,,,2008-04-12T01:28:02Z,,0,0,090000648049eeef
FDA-2002-P-0291-0003,FDA,FDA-2002-P-0291,"FDA/CDER to Teva Pharmaceuticals USA, Inc.",Other,PAV-Petition Approval,2002-06-12T04:00:00Z,2002,6,,,2008-04-12T01:28:02Z,,0,0,090000648049eee9
FDA-2002-P-0291-0002,FDA,FDA-2002-P-0291,"FDA/DDM to Teva Pharmaceuticals USA, Inc.",Other,ACK-Acknowledgement Letter,2002-04-30T04:00:00Z,2002,4,,,2008-04-12T01:28:02Z,,0,0,090000648049eece
FDA-2002-P-0291-0001,FDA,FDA-2002-P-0291,"FDA/DDM to Teva Pharmaceuticals USA, Inc.",Other,ACK-Acknowledgement Letter,2002-04-30T04:00:00Z,2002,4,,,2008-04-12T01:28:02Z,,0,0,090000648049eea0